Aclaris Therapeutics
ACRS
#8131
Rank
โ‚ฌ0.18 B
Marketcap
2,60ย โ‚ฌ
Share price
-1.81%
Change (1 day)
168.40%
Change (1 year)

Aclaris Therapeutics (ACRS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ50.03 Million

According to Aclaris Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ50.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aclaris Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ36.38 M-31.49%
2022-12-31โ‚ฌ53.11 M11.66%
2021-12-31โ‚ฌ47.56 M76.58%
2020-12-31โ‚ฌ26.93 M6.31%
2019-12-31โ‚ฌ25.33 M-52.04%
2018-12-31โ‚ฌ52.83 M247.42%
2017-12-31โ‚ฌ15.2 M142.55%
2016-12-31โ‚ฌ6.26 M340.87%
2015-12-31โ‚ฌ1.42 M-95.46%
2014-12-31โ‚ฌ31.35 M85.28%
2013-12-31โ‚ฌ16.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ26.88 M-46.26%๐Ÿ‡บ๐Ÿ‡ธ USA